About Enhancer

Enhancer ID: E_01_0798
Species: human
Position : chr4:109910279-109912279
Biosample name:
Experiment class : High+Lowthroughput
Enhancer type: Enhancer
Disease: Colorectal adenocarcinoma
Pubmed ID:  30022673
Enhancer experiment: NF - ? B assay, flow cytometry, statistical analysis, immunofluorescence staining
Enhancer experiment description: The immortalised cells were routinely propagated in Opti-MEM, supplemented with 4% v/v fetal bovine serum (FBS), 2mM L-glutamine, 2mM GlutaMAX, 10mM 4-(2-hydroxyethyl)-1-piperazineethanesul- phonic acid (HEPES), 20ng/ml Epidermal Growth Factor (EGF), 10 g/ml insulin, and 150nM hydrocor- tisone, and were incubated at 32 C, 6% v/v CO 2 in a humidified atmosphere.

About Target gene

Target gene : --
Strong evidence: qRT-PCR,qPCR,ChIP,3C
Less strong evidence: RNA-Seq
Target gene experiment description: The immortalised cells were routinely propagated in Opti-MEM, supplemented with 4% v/v fetal bovine serum (FBS), 2mM L-glutamine, 2mM GlutaMAX, 10mM 4-(2-hydroxyethyl)-1-piperazineethanesul- phonic acid (HEPES), 20ng/ml Epidermal Growth Factor (EGF), 10 g/ml insulin, and 150nM hydrocor- tisone, and were incubated at 32 C, 6% v/v CO 2 in a humidified atmosphere.

About TF

TF name : EGF(HOMG4,URG)
TF experiment: NF-?B assay,?????,????,??????
TF experiment description: The immortalised cells were routinely propagated in Opti-MEM, supplemented with 4% v/v fetal bovine serum (FBS), 2mM L-glutamine, 2mM GlutaMAX, 10mM 4-(2-hydroxyethyl)-1-piperazineethanesul- phonic acid (HEPES), 20ng/ml Epidermal Growth Factor (EGF), 10 g/ml insulin, and 150nM hydrocor- tisone, and were incubated at 32 C, 6% v/v CO 2 in a humidified atmosphere.

About Function

Enhancer function : The immortalised cells were routinely propagated in Opti-MEM, supplemented with 4% v/v fetal bovine serum (FBS), 2mM L-glutamine, 2mM GlutaMAX, 10mM 4-(2-hydroxyethyl)-1-piperazineethanesul- phonic acid (HEPES), 20ng/ml Epidermal Growth Factor (EGF), 10 g/ml insulin, and 150nM hydrocor- tisone, and were incubated at 32 C, 6% v/v CO 2 in a humidified atmosphere.
Enhancer function experiment: Immunohistochemical staining
Enhancer function
experiment description:
The immortalised cells were routinely propagated in Opti-MEM, supplemented with 4% v/v fetal bovine serum (FBS), 2mM L-glutamine, 2mM GlutaMAX, 10mM 4-(2-hydroxyethyl)-1-piperazineethanesul- phonic acid (HEPES), 20ng/ml Epidermal Growth Factor (EGF), 10 g/ml insulin, and 150nM hydrocor- tisone, and were incubated at 32 C, 6% v/v CO 2 in a humidified atmosphere.

About SNP

SNP ID: --

Upstream Pathway Annotation of TF

GeneName Pathway Name Source Gene Number
EGF a6b1 and a6b4 Integrin signaling pid 46
EGF Arf6 signaling events pid 36
EGF Ceramide signaling pathway pid 49
EGF Constitutive Signaling by Aberrant PI3K in Cancer reactome 61
EGF Constitutive Signaling by EGFRvIII reactome 15
EGF Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants reactome 19
EGF EGF receptor signaling pathway panther 109
EGF EGF signaling pathway ( EGF signaling pathway Diagram ) inoh 13
EGF EGFR-dependent Endothelin signaling events pid 9
EGF EGFR downregulation reactome 27
EGF EGFR1 netpath 475
EGF ErbB receptor signaling network pid 15
EGF ErbB1 downstream signaling pid 105
EGF ERBB2 Activates PTK6 Signaling reactome 13
EGF ERBB2 Regulates Cell Motility reactome 15
EGF GAB1 signalosome reactome 11
EGF GRB2 events in EGFR signaling reactome 7
EGF GRB2 events in ERBB2 signaling reactome 16
EGF Heterotrimeric GPCR signaling pathway (through G alpha i and pertussis toxin) ( GPCR signaling (pertussis toxin) ) inoh 228
EGF Heterotrimeric GPCR signaling pathway (through G alpha q, PLC beta and ERK cascade) ( GPCR signaling (G alpha q) ) inoh 239
EGF Heterotrimeric GPCR signaling pathway (through G alpha s ACs Epac BRaf and ERKcascade) ( GPCR signaling (G alpha s, Epac and ERK) ) inoh 237
EGF Heterotrimeric GPCR signaling pathway (through_G alpha s_ACs_PKA_BRaf_and_ERKcascade)(canonical) ( GPCR signaling (G alpha s, PKA and ERK) ) inoh 227
EGF Heterotrimeric GTP-binding protein coupled receptor signaling pathway (through G alpha i, adenylate cyclase and cAMP) ( GPCR signaling (G alpha i) ) inoh 228
EGF Heterotrimeric GTP-binding protein coupled receptor signaling pathway (through_G_alpha_s,_cholera_toxin,_adenylate_cyclase_and_cAMP) ( GPCR signaling (cholera toxin) ) inoh 227
EGF Internalization of ErbB1 pid 38
EGF PI3K events in ERBB2 signaling reactome 16
EGF PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling reactome 83
EGF PIP3 activates AKT signaling reactome 81
EGF Platelet degranulation reactome 107
EGF Posttranslational regulation of adherens junction stability and dissassembly pid 50
EGF RAF/MAP kinase cascade reactome 116
EGF Regulation of Telomerase pid 70
EGF SHC1 events in EGFR signaling reactome 8
EGF SHC1 events in ERBB2 signaling reactome 18
EGF SHP2 signaling pid 60
EGF Signaling by EGFR reactome 7
EGF Signaling by ERBB2 reactome 25
EGF Signaling by ERBB4 reactome 11
EGF Signaling events mediated by PTP1B pid 53
EGF Signaling events mediated by TCPTP pid 40
EGF Stabilization and expansion of the E-cadherin adherens junction pid 43
EGF Thromboxane A2 receptor signaling pid 56
EGF MAPK signaling pathway kegg 264
EGF ErbB signaling pathway kegg 83
EGF Cytokine-cytokine receptor interaction kegg 213
EGF Endocytosis kegg 201
EGF Focal adhesion kegg 197
EGF Gap junction kegg 87
EGF Regulation of actin cytoskeleton kegg 210
EGF Hepatitis C kegg 134
EGF Pathways in cancer kegg 321
EGF Pancreatic cancer kegg 70
EGF Endometrial cancer kegg 52
EGF Glioma kegg 65
EGF Prostate cancer kegg 85
EGF Melanoma kegg 69
EGF Bladder cancer kegg 38
EGF Non-small cell lung cancer kegg 54
EGF Hs_Nucleotide-binding_Oligomerization_Domain_(NOD)_pathway_WP1433_86035 wikipathways 37
EGF Hs_Bladder_Cancer_WP2828_89143 wikipathways 17
EGF Hs_ERK_Pathway_in_Huntington's_Disease_WP3853_89748 wikipathways 10

Enhancer associated network

The number on yellow line represents the distance between enhancer and target gene

Expression of target genes for the enhancer


Enhancer associated SNPs